Measures that target Russia’s core industries will depress consumption and investment
Tim Kobe, the man behind the Apple Store's signature touches, remembers what Jobs taught him about retail design
In offering conflicting opinions within hours, two federal courts have set up a fight at the Supreme Court over the Affordable Care Act
Xiaomi Chief Executive Officer Lei Jun unveils the Mi4, a metal-backed iPhone-esque smartphone with a 5-inch display, the latest Qualcomm Snapdragon chip, and a $320 price tag
A months-long public-relations debacle is taking a heavy toll on the operators of dark pools
The furniture manufacturer of midcentury classics acquires its largest retail outlet
That an accordion-playing parodist has become one of the most enduring musical acts of our time is, well, a little weird
A new report shows young college-educated professionals will wait a long time to see the financial rewards of their degree.
Profiled companies pay the recruiting service, but job-seekers don't
Founders: Dr. Samir Patel and Dr. David Guyer
VC Investment over the last four quarters: $37.47 million
Founded in 2007, the 15-employee Ophthotech is a biotech company developing treatments for age-related macular degeneration, a common cause of vision loss in older adults. The co-founders' prior venture, Eyetech, was acquired by OSI Pharmaceuticals (OSIP) in 2005 in a deal valued at $900 million.
Key to startup success: "[Our] in-depth understanding of the specific specialty pharma space, coupled with an experienced management and venture investors, has been key to our success."